High diversity of non-human leukocyte antigens in transplant-associated coronary artery disease

被引:12
作者
Bates, RL
Frampton, G
Rose, ML
Murphy, JJ [1 ]
机构
[1] Univ London Kings Coll, Div Life Sci, London SE1 9NN, England
[2] Wolverhampton Univ, Mol Immunol Res Grp, Sch Appl Sci, Wolverhampton, England
[3] Imperial Coll Sch Med, Natl Heart & Lung Inst, Harefield Hosp, London, England
关键词
D O I
10.1097/01.TP.0000061790.08550.EC
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Antibodies to endothelial derived non-human leukocyte antigens (HIA) have been associated with transplant (Tx)-associated coronary artery disease (CAD) after cardiac transplantation; however, few have been identified. The aim of this study was to screen a human coronary artery endothelial cell cDNA library with patient sera to establish-the diversity and nature of the target antigens. Methods. A human coronary artery endothelial cell cDNA library was screened with sera from seven long-term cardiac transplant patients with angiographically diagnosed TxCAD and sera from five healthy volunteers. Results. Of the seven patients' sera, five showed reactivity, as did sera from. two of the five normal subjects. Eighteen positive cDNA clones were isolated by TxCAD sera; DNA sequence analysis and DNA database searching identified all but one clone; 16 ere nuclear or cytoplasmic proteins and 1 of them was the cell surface protein neuropilin 2. Five clones were targeted by normal, sera. A different spectrum of reactive clones was identified by the sera of each patient where reactive clones were evident. Conclusions. A high diversity of non-HLA antigens, probably autoantigens, are involved in the pathogenesis of TxCAD.
引用
收藏
页码:1347 / 1350
页数:4
相关论文
共 25 条
[1]   Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III [J].
Chen, H ;
Chedotal, A ;
He, ZG ;
Goodman, CS ;
TessierLavigne, M .
NEURON, 1997, 19 (03) :547-559
[2]  
Costanzo MR, 1998, J HEART LUNG TRANSPL, V17, P744
[3]   ANTIENDOTHELIAL ANTIBODIES AND CORONARY-ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION [J].
DUNN, MJ ;
CRISP, SJ ;
ROSE, ML ;
TAYLOR, PM ;
YACOUB, MH .
LANCET, 1992, 339 (8809) :1566-1570
[4]  
Fedoseyeva EV, 1999, J IMMUNOL, V162, P6836
[5]   The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation [J].
Fredrich, R ;
Toyoda, M ;
Czer, LSC ;
Galfayan, K ;
Galera, O ;
Trento, A ;
Freimark, D ;
Young, S ;
Jordan, SC .
TRANSPLANTATION, 1999, 67 (03) :385-391
[6]   Direct and indirect pathways of alloantigen recognition: relevance to acute and chronic allograft rejection [J].
Hornick, P ;
Lechler, R .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (09) :1806-1810
[7]   Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection [J].
Hornick, PI ;
Mason, PD ;
Baker, RJ ;
Hernandez-Fuentes, M ;
Frasca, L ;
Lombardi, G ;
Taylor, K ;
Weng, L ;
Rose, ML ;
Yacoub, MH ;
Batchelor, R ;
Lechler, RI .
CIRCULATION, 2000, 101 (20) :2405-2410
[8]   Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation [J].
Jurcevic, S ;
Ainsworth, ME ;
Pomerance, A ;
Smith, JD ;
Robinson, DR ;
Dunn, MJ ;
Yacoub, MH ;
Rose, ML .
TRANSPLANTATION, 2001, 71 (07) :886-892
[9]  
Kitsukawa T, 1995, DEVELOPMENT, V121, P4309
[10]   Screening of a HUVEC cDNA library with transplant-associated coronary artery disease sera identifies RPL7 as a candidate autoantigen associated with this disease [J].
Linke, AT ;
Marchant, B ;
Marsh, P ;
Frampton, G ;
Murphy, J ;
Rose, ML .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 126 (01) :173-179